Problem statement: Answer the multiple choice question.
Query: Which compound exhibits a -23.056% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) CCCC(=O)OC/C(O)=C(\C#N)c1nc2ccccc2[nH]1
b.) CC1CN(c2nnnn2-c2ccccc2)CC(C)O1
c.) Oc1c(C(c2cccs2)N2CCOCC2)sc2ncnn12
d.) COCCNC(=O)c1cccc(OC2CCN(Cc3cccc(C(C)=O)c3)CC2)c1
e.) CCOC(=O)N1CCN(C(=O)CSc2ccc(-c3cccc(OC)c3)nn2)CC1
Answer: b. CC1CN(c2nnnn2-c2ccccc2)CC(C)O1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CN(c2nnnn2-c2ccccc2)CC(C)O1
CC1CN(c2nnnn2-c2ccccc2)CC(C)O1
2,6-dimethyl-4-(1-phenyltetrazol-5-yl)morpholine